Xencor (XNCR) stock rose 25% to $31.36 after XmAb819 kidney cancer data. See the response rates, FDA plans and analyst targets.
GSK, the FTSE 100 drugmaker, said its immunotherapy Jemperli (dostarlimab) produced a complete response in 76% of patients ...
It seems we cannot go a week without hearing about some new health or beauty craze, usually on social media sites that cater ...
Onco360 ®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by AstraZeneca Pharmaceuticals for Zegfrovy ® (sunvozertinib), which is indicated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results